-
Ex-Broncos' Randy Gregory Sues NFL For Blocking Prescribed Medical Cannabis Treatment & Fining Him Over $532K
Friday, June 7, 2024 - 5:18pm | 832Former Denver Broncos linebacker Randy Gregory filed a lawsuit against the NFL and the team on Wednesday for preventing him from using prescribed synthetic cannabis. Gregory, now with the Tampa Bay Buccaneers, says he was fined $532,000 from his salary for testing positive for Dronabinol, an FDA-...
-
Cannabis Treatment Improves Cognitive Function, Reduces Pain And Depression Among Advanced Cancer Patients, New Study
Friday, December 22, 2023 - 11:30am | 548Pain, poor appetite, depression and sleep issues are some of the challenges affecting patients with advanced cancer. Can marijuana help? A new study, conducted by Danish researchers, revealed that low doses of oral THC (dronabinol) improve cognitive function in...
-
FDA-Approved Synthetic THC Trials Show 21% Tic Reduction In Tourette Syndrome Patients
Sunday, November 12, 2023 - 10:09pm | 393SciSparc Ltd. (NASDAQ: SPRC), a clinical-stage pharmaceutical company, reported a new Phase IIb trial of SCI-110, a proprietary THC-based medication for Tourette Syndrome (TS) treatment. Global Collaboration for TS Advancements Spanning across renowned institutions such as Yale University, Tel Aviv...
-
Study: Dangerous Synthetic Cannabinoids Poisonings Are Less Common In Legal Cannabis States
Tuesday, August 9, 2022 - 9:28am | 940Illegal synthetic cannabis known under many street names such as Ak-47, K2, Spice, Scoobie Snacks, Mr. Nice Guy and 24-Karat Dream is less commonly used in states that have legal marijuana programs, a Washington State University-led study recently confirmed. The research published in the...
-
RespireRx Pharmaceuticals Files Patent: Claims To Improve Solubility & Bioavailability Of Cannabinoids
Thursday, March 24, 2022 - 9:13am | 369RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) in association with Jeffrey King managing attorney at Patent Networks Law Group, has filed a provisional patent application describing novel lipid-based formulation technology that may be used to improve the solubility and bioavailability of poorly...
-
Canopy Growth Acquires Germany-Based C3 Cannabinoid Compound Company For $254M
Thursday, May 2, 2019 - 1:37pm | 366Canopy Growth Corp (NYSE: CGC) is strengthening its presence in Germany and Europe with the acquisition of C3 Cannabinoid Compound Company, a leading manufacturer and distributor of dronabinol, a synthetic cannabinoid. What Happened The value of the transaction is 225.9 million euro (about $254...